Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04680481 · ClinicalTrials.gov registry record · NA
Non-Invasive Brain Stimulation to Control Large-Scale Brain Networks
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04680481: Completed NA study, sponsored by University of Minnesota.
NCT04680481 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04680481, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This project will assess the feasibility of traveling wave transcranial alternating current stimulation (tACS) to modify working memory performance and large-scale brain connectivity in surgical epilepsy patients.
Primary Outcome
Changes in spectral power and coherence of the local field potentials during transcranial electric stimulation relative to no stimulation periods.
Interventions
- DEVICE Transcranial alternating current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the finished NCT04680481 record still lists
NCT04680481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcranial alternating current stimulation is the first listed.
NCT04680481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04680481 about?
NCT04680481 is a clinical study titled "Non-Invasive Brain Stimulation to Control Large-Scale Brain Networks". This project will assess the feasibility of traveling wave transcranial alternating current stimulation (tACS) to modify working memory performance and large-scale brain connectivity in surgical epilepsy patients.
What is the current status of trial NCT04680481?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-11-01. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT04680481?
The interventions under investigation include: Transcranial alternating current stimulation (DEVICE).
Who is sponsoring clinical trial NCT04680481?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04680481's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI